603976
XSHG
Market cap647mUSD
Nov 20, Last price
25.20CNY
1D
-10.00%
1Q
-9.25%
IPO
55.56%
Name
CHONGQING ZHENGCHUAN PHARMAC PCKG CO LTD
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
ChongQing Zhengchuan Pharmaceutical Packaging Co.,Ltd. specializes in the research, development, manufacturing, and sale of various glass packaging solutions for the pharmaceutical industry across China. Their extensive product line includes medium borosilicate glass ampoule and injection bottles, low borosilicate tubular vials and ampoules, oral liquid vials, and screw-neck vials. The company also provides plastic flip-off and aluminum caps, as well as borosilicate and soda-lime glass control bottles. Established in 1988, the firm's headquarters are situated in Chongqing, China.
Key people
Hanrong Xiao
Finance Director · since 2019
Qiuhan Deng
General Manager, Director · since 2022
Yong Deng
Chairman of the Board · since 2022
Feng'an Jiang
Deputy General Manager, Director · since 2019
Shiping Fei
Secretary of the Board · since 2023
Jiyang Chen
Director · since 2023
Zhengde Li
Director · since 2025
Qing Xiao
Deputy General Manager, Director · since 2019
Wenyan Hu
Independent Director · since 2022
Lihong Pan
Independent Director · since 2019
Dajun Wang
Independent Director · since 2025
Xixiong Xu
Independent Director · since 2022
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||